Presentation is loading. Please wait.

Presentation is loading. Please wait.

SUBLINGUAL IMMUNOTHERAPY Giovanni Passalacqua Allergy & Respiratory Diseases Dept.Internal Medicine- University of Genoa ITALY.

Published byDonna Maria Wells Modified over 8 years ago

Similar presentations

Presentation on theme: "SUBLINGUAL IMMUNOTHERAPY Giovanni Passalacqua Allergy & Respiratory Diseases Dept.Internal Medicine- University of Genoa ITALY."— Presentation transcript:

1 SUBLINGUAL IMMUNOTHERAPY Giovanni Passalacqua Allergy & Respiratory Diseases Dept.Internal Medicine- University of Genoa ITALY

2 THE LITERATURE 66 RDBPC TRIALS 8 RANDOMIZED OPEN TRIALS 6 COMPARATIVE (SLIT vs SCIT) 6 TRIALS IN OTHER DISEASES

3 10 20 grass HDM parietaria cypress cat ragweed birch other 67%

4 Less or equal 6 months: 23 studies Less or equal 12 months: 15 studies More than 12 months: 20 studies TREATMENT DURATION < 20 : 4 studies < 50 : 21 studies < 100 : 16 studies PATIENTS ENROLLED < 150 : 11 studies > 150 : 8 studies

5 10 STUDIES WITH SAMPLE SIZE CALCULATION Durham 2006De Blay, 2007 Dahl 2006Pfaar 2008 Pham Ti 2007Wahn 2009 Roder 2006Ott 2009 Didier 2007Bufe 2009 Skoner 2010Cortellini 2010

6 Sublingual immunotherapy with once-daily grass allergen tablets: A randomized controlled trial in seasonal allergic rhinoconjunctivitis Durham SR, JACI 2006

7 Prolonged preseasonal treatment with Grazax improves the clinical efficacy Calderon M et al, Allergy 2007

8

9

10 Efficacy and safety of sublingual immunotherapy with grass allergen tablets for seasonal allergic rhinoconjunctivitis. Dahl et al, JACI 2006 VERSUS PLACEBO: SYMPTOM REDUCTION - 30% MEDICATION REDUCTION - 38% 634 PATIENTS !!!

11 VS PLACEBO Symptoms -28% (-39%) Medications - 24% (-48%) Efficacy and safety of 5- grass-pollen sublingual immunotherapy tablets in pediatric allergic rhinoconjunctivitis Wahn 2009

12 VS PLACEBO Symptoms -34% to –44%

13 VS PLACEBO Symptoms -24% Medications - 34%

14 Sublingual immunotherapy for allergic rhinitis. Allergy, 2005. Wilson D., Torres Lima I, Durham S. 21 trials

15 Efficacy of sublingual immunotherapy in the treatment of allergic rhinitis in pediatric patients: Meta-analysis of randomized controlled trials. Martin Penagos, Enrico Compalati, Francesco Tarantini, Rodrigo Baena Cagnani, Jose Huerta Lopez, Giovanni Passalacqua and Giorgio Walter Canonica 2006

16 Meta-analysis of the efficacy of sublingual immunotherapy in allergic asthma in pediatric patients, 3 to 18 years of age. M Penagos, G Passalacqua, E Compalati, C Baena-Cagnani, S Orozco, A Pedroza GW Canonica

17 SCITSLIT Clinical efficacy: RhinitisIa Clinical Efficacy: AsthmaIa Clinical efficacy: Children (rhinitis) Children (asthma) Ib Ia Prevention of new sensitizationsIbIIa Longterm effectIbIIa Prevention of asthmaIIb ARIA Update on immunotherapy SR Durham and G.Passalacqua JACI 2007 in press

18 Abramson 2003 AsthmaA-Cp< 0.01 Calamita 2006AsthmaA-CP= 0.07 Penagos 2008AsthmaCP= 0.02 Olaguibel 2005 Asthma /Rhinitis CP= 0.01 Calderon 2007RhinitisAp< 0.01 Penagos 2006RhinitisCp= 0.02 Wilson 2005RhinitisA-Cp= 0.002 A = adults C = children Specific immunotherapy for respiratory allergy: state of the art according to current meta- analyses. Compalati E et al, Ann Allergy Asthma Immunol 2009 Meta analisi: sintomi SCIT SLIT

19 49 (OUT OF 60) RDBPC TRIALS SUITABLE FOR POOLING: 2333 SLIT 2256 PLACEBO

20 SYMPTOM SCORE

21 MEDICATION SCORE

22 Symptom Score Rhintis

23 JACI 2010

24

25 No fatal event reported since 1986 SLIT

26 Author, year Sex (age) Allergen (producer) PhaseOnsetDescription Epineph rine De Groot, 2009 M (13)Grass (Grazax, ALK-Abellò) First dose15 minGeneralized urticaria, swelling of tongue NO De Groot, 2009 F (27)Grass (Grazax, ALK-Abellò) First dose5 minAbdominal cramps, asthma, generalized itching, hypotension YES Blazowski, 2008 F (16)HDM (Staloral, Stallergenes) Maintenance overdose (60 drops) 10 minHypotension- collapse, flushing, urticaria YES Eifan, 2008 F (11)dust mite + grass pollen mix (Stallergenes) Maintenance. 3 minAbdominal pain, chest pain, fever, nausea Not specified Dunski, 2006 F (31)Alternaria, cat, dog grass, ragweed, (Greer) 2 nd day of updosing 5 minAngioedema, dizziness, dyspnea, generalized itching NO Antico, 2006 F (36)LatexEnd of rush buildup 10 minAsthma, generalized urticaria Not specified Anaphylaxis with SLIT

27 Cox L, Linneman D, Nolte H, Weldon D, Finegold I, Nelson HS. Sublingual immunotherapy: A comprehensive review. J Allergy Clin Immunol 2006; 117: 1021-35 In 41 studies with information on the total number of AEs, 1047 adverse reactions in a total of 386,149 doses were identified (2.7 reactions/1,000 doses). In 49 studies with information on the number of patients, the AEs were 529 per 4378 patients (12%). In the trials that specified the severity of reaction, the occurrence of severe AE was 0.56 per 1,000 doses. Overall, 14 serious AEs probably related to the treatment were found.

28 AuthorN patsAge rangeFollow- up AE % of patients AE/1,000 doses Di Rienzo2682-15 years3 years3 %0.1/1,000 Lombardi198> 14 years3 years7.5 %0.5/1,000 Pajno3545-15 years36 months6 %0.15/1,000 Agostinis363-5 years2 years5 %0.07/1,000 Di Rienzo1283-5 years2 years5. 6%0.2/1,000 SLIT: POST MARKETING SURVEYS

29 THE SAFETY OF SUBLINGUAL IMMUNOTHERAPY WITH ONE OR MORE ALLERGENS IN CHILDREN Fabio Agostinis, Marcello Cottini, Carlo Lombardi, Giorgio Walter Canonica, Giovanni Passalacqua, Allergy 2008 in press SINGLE ALLERGEN n (%)MULTI ALLERGENS n (%) Grass140 (82)Grass + pariet6 (2) Parietaria4 (3)Grass+ olive18 (7) Birch14 (9)Grass + birch +alder+hazelnut 220 (87) Ragweed4 (3)Grass + ragweed9 (4) Olive-Grass + mugwort Birch+hazelnut +alder TOTAL172 (100) 253 (100) 415 children, 3-18 years, 272 male

30 Coseasonal SLIT reduces the development of asthma in children with allergic rhinitis. Novembre E. et al, JACI 2004 SLITNO SLIT 37 8 26 18 NO ASTHMA ASTHMA 79 children Allergic rhinitis only Follow-up: 3 yrs

31 PREVENTIVE EFFECTS OF SUBLINGUAL IMMUNOTHERAPY IN CHILDHOOD. AN OPEN RANDOMIZED CONTROLLED STUDY MAURIZIO MAROGNA MD 1, D.TOMASSETTI 1, A. BERNASCONI 1, F.COLOMBO 1, ALESSANDRO MASSOLO BS 2, A. DI RIENZO BUSINCO 4, GIORGIO W CANONICA MD 3, GIOVANNI PASSALACQUA MD 3 AND SALVATORE TRIPODI MD 4 1 Pneumology Unit, Cuasso al Monte, Macchi Hospital Foundation, Varese 2 Department of Animal Biology, University of Pavia, Pavia 3 Allergy & Respiratory Diseases,Department of Internal Medicine, Genoa University 4 Pediatric Allergy Unit, S. Pertini Hospital, Rome AAAI 2008, 101: 261

32 Diary card Visit Skin test MCh challenge 144 SLIT 72 CONTROLS 14 dropout 6 dropout 1 year BASELINE RANDOMIZED PHASE Year 1 PATIENTS 216 Year 2Year 3 * ****** * * * * * 130 SLIT 66 CONT

33 CONTROLS NS *** baseline3rd year PERSISTENT ASTHMA 10 20 30 40 50 60 70 % PATIENTS SLIT *** baseline3rd year MONOSENSITIZED PATIENTS 10 20 30 40 50 60 70 % PATIENTS

34

Download ppt "SUBLINGUAL IMMUNOTHERAPY Giovanni Passalacqua Allergy & Respiratory Diseases Dept.Internal Medicine- University of Genoa ITALY."

Similar presentations

Why immunotherapy fails ? Stephen Durham Imperial College and Royal Brompton Hospital, London UK.

Why immunotherapy fails ? Stephen Durham Imperial College and Royal Brompton Hospital, London UK.
Allergen Immunotherapy: From Shots to Tablets Susan Waserman MSc MDCM FRCPC Professor of Medicine Division of Clinical Allergy and Immunology Life and.

Allergen Immunotherapy: From Shots to Tablets Susan Waserman MSc MDCM FRCPC Professor of Medicine Division of Clinical Allergy and Immunology Life and.
Module 4: Immunotherapy Updated: June 2011 Global Resources in Allergy (GLORIA™) Global Resources In Allergy (GLORIA™) is the flagship program of the.

Module 4: Immunotherapy Updated: June 2011 Global Resources in Allergy (GLORIA™) Global Resources In Allergy (GLORIA™) is the flagship program of the.
Subject: Introdução à Medicina Long-term preventive effects of allergen specific immunotherapy: a systematic review and meta-analysis.

Subject: Introdução à Medicina Long-term preventive effects of allergen specific immunotherapy: a systematic review and meta-analysis.
Immunopathological reaction (reaction of hypersensitivity) type I.

Immunopathological reaction (reaction of hypersensitivity) type I.
Dr Narayana pradeep Consultant Pulmonologist Carewell hospital KasaragodKERALA.

Dr Narayana pradeep Consultant Pulmonologist Carewell hospital KasaragodKERALA.
Grazie per aver scelto di utilizzare a scopo didattico questo materiale delle Guidelines 2011 libra. Le ricordiamo che questo materiale è di proprietà.

Grazie per aver scelto di utilizzare a scopo didattico questo materiale delle Guidelines 2011 libra. Le ricordiamo che questo materiale è di proprietà.
Dermot Ryan, FRCGP, Woodbrook Medical Centre, Loughborough, United Kingdom Allergy and Respiratory Research Group, Centre for Population Health Sciences:

Dermot Ryan, FRCGP, Woodbrook Medical Centre, Loughborough, United Kingdom Allergy and Respiratory Research Group, Centre for Population Health Sciences:
Agency for Healthcare Research and Quality (AHRQ)

Agency for Healthcare Research and Quality (AHRQ)
CURRENT STATUS OF SUBLINGUAL IMMUNOTHERAPY IN THE U.S. Michael S. Blaiss, MD Clinical Professor of Pediatrics and Medicine University of Tennessee Health.

CURRENT STATUS OF SUBLINGUAL IMMUNOTHERAPY IN THE U.S. Michael S. Blaiss, MD Clinical Professor of Pediatrics and Medicine University of Tennessee Health.
Understand the Difference between Local and Systemic Reactions Michael S. Blaiss, MD Clinical Professor of Pediatrics and Medicine University of Tennessee.

Understand the Difference between Local and Systemic Reactions Michael S. Blaiss, MD Clinical Professor of Pediatrics and Medicine University of Tennessee.
Use of Multiple Allergen Mixes in Immunotherapy Harold S. Nelson, MD Professor of Medicine National Jewish Health University of Colorado Denver School.

Use of Multiple Allergen Mixes in Immunotherapy Harold S. Nelson, MD Professor of Medicine National Jewish Health University of Colorado Denver School.
Authors: Petersen KD §1, Kronborg C 2, Beck SJ 3, Larsen JN 4, Dahl R 5, Gyrd-Hansen D 2, 6 §1 Corresponding: Karin Dam Petersen, Danish Centre for Healthcare.

Authors: Petersen KD §1, Kronborg C 2, Beck SJ 3, Larsen JN 4, Dahl R 5, Gyrd-Hansen D 2, 6 §1 Corresponding: Karin Dam Petersen, Danish Centre for Healthcare.
Main difference: time required to reach maintenance dose.

Main difference: time required to reach maintenance dose.
T-cell Immunoregulation and the Response to Immunotherapy Harold S. Nelson. MD Professor of Medicine National Jewish Health and University of Colorado.

T-cell Immunoregulation and the Response to Immunotherapy Harold S. Nelson. MD Professor of Medicine National Jewish Health and University of Colorado.
Allergy Symptom Response Following Conversion from Injection Immunotherapy to Sublingual Immunotherapy CDR Timothy Clenney, MD, MPH Naval Medical Center.

Allergy Symptom Response Following Conversion from Injection Immunotherapy to Sublingual Immunotherapy CDR Timothy Clenney, MD, MPH Naval Medical Center.
Anti-IgE in Asthma and Other Allergic Diseases Harold S. Nelson. MD Professor of Medicine National Jewish Health And University of Colorado School of Medicine.

Anti-IgE in Asthma and Other Allergic Diseases Harold S. Nelson. MD Professor of Medicine National Jewish Health And University of Colorado School of Medicine.
SLIT: dealing with trouble, doing it right. Giovanni B Pajno MD Professor of Pediatrics Department of Pediatrics – Allergy Unit University of Messina Italy.

SLIT: dealing with trouble, doing it right. Giovanni B Pajno MD Professor of Pediatrics Department of Pediatrics – Allergy Unit University of Messina Italy.
Rush and Cluster Immunotherapy Harold S. Nelson, MD Professor of Medicine National Jewish Health University of Colorado Health Science Center Denver, Colorado.

Rush and Cluster Immunotherapy Harold S. Nelson, MD Professor of Medicine National Jewish Health University of Colorado Health Science Center Denver, Colorado.
EVALUATION OF THREE ALLERGEN SPECIFIC IMMUNOTHERAPY METHODS Standard Injection RUSH Injection Sublingual Abstract# 54 Richard Herrscher M.D. FACAAI Clinical.

EVALUATION OF THREE ALLERGEN SPECIFIC IMMUNOTHERAPY METHODS Standard Injection RUSH Injection Sublingual Abstract# 54 Richard Herrscher M.D. FACAAI Clinical.

Similar presentations

Ads by Google